CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Central Venous Access Placementdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03209050
NCT03209050N/ACompleted
CompareCT.gov

Evaluation of the Surfacer System Approach to Central Venous Access

Merit Medical Systems, Inc.·interventional·Posted Jul 6, 2017·Updated May 30, 2023

In Brief

A clinical study evaluating Central Venous Access Placement for Venous Occlusion. Completed, enrolled 30 participants across 1 site.

Detailed Summary

Pre-market Investigational device exemption study evaluating the safety and efficacy of the Surfacer System to facilitate stable upper body central venous access suitable for any conventional catheter.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVenous Occlusion
CountriesUnited States
CollaboratorsMeditrial Europe Ltd.

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJul 6, 2017
Enrollment StartDec 18, 2017
Primary CompletionMay 24, 2019
Study CompletionJun 1, 2019
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 9.0 years ago

Interventions

Central Venous Access Placementdevice

Device inserted into the femoral vein to insert a central venous access catheter